Skip to main content
SpringerLink
Log in

Grundlagen der gastrointestinalen Tumorerkrankungen

  • Chapter
  • First Online:
Viszeralmedizin

  • 5294 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 149.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

Literatur zu Abschnitt 28.1

  • Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13(1):11–26

    CAS  PubMed  Google Scholar 

  • Banerjee S, Kaye S (2011) PARP inhibitors in BRCA gene-mutated ovarian cancer and beyond. Curr Oncol Rep 13(6):442–449

    CAS  PubMed  Google Scholar 

  • Baselga J, Swain SM (2009) Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 9(7):463–475

    CAS  PubMed  Google Scholar 

  • Bradish JR, Montironi R, Lopez-Beltran A, Post KM, MacLennan GT, Cheng L (2013) Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations. Future Oncol 9(2):245–253

    CAS  PubMed  Google Scholar 

  • Brosh RM Jr (2013) DNA helicases involved in DNA repair and their roles in cancer. Nat Rev Cancer 13(8):542–558

    CAS  PubMed  Google Scholar 

  • Capaccione KM, Pine SR (2013) The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis 34(7):1420–1430

    PubMed Central  CAS  PubMed  Google Scholar 

  • Chikamori K, Grozav AG, Kozuki T, Grabowski D, Ganapathi R, Ganapathi MK (2010) DNA topoisomerase II enzymes as molecular targets for cancer chemotherapy. Curr Cancer Drug Targets 10(7):758–771

    CAS  PubMed  Google Scholar 

  • De P, Miskimins K, Dey N, Leyland-Jones B (2013) Promise of rapalogues versus mTOR kinase inhibitors in subset specific breast cancer: old targets new hope. Cancer Treat Rev 39(5):403–412

    CAS  PubMed  Google Scholar 

  • Gerald D, Chintharlapalli S, Augustin HG, Benjamin LE (2013) Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy. Cancer Res 73(6):1649–1657

    CAS  PubMed  Google Scholar 

  • Gyrd-Hansen M, Meier P (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10(8):561–574

    CAS  PubMed  Google Scholar 

  • Harvey KF, Zhang X, Thomas DM (2013) The Hippo pathway and human cancer. Nat Rev Cancer 13(4):246–257

    CAS  PubMed  Google Scholar 

  • Hilgart JS, Coles B, Iredale R (2012) Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database Syst Rev 2:CD003721

    PubMed  Google Scholar 

  • Huang Y, Goel S, Duda DG, Fukumura D, Jain RK (2013) Vascular normalization as an emerging strategy to enhance cancer immunotherapy. Cancer Res 73(10):2943–2948

    PubMed Central  CAS  PubMed  Google Scholar 

  • Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD (2009) Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer 9(3):182–194

    PubMed Central  CAS  PubMed  Google Scholar 

  • Kershaw MH, Westwood JA, Darcy PK (2013) Gene-engineered T cells for cancer therapy. Nat Rev Cancer 13(8):525–541

    CAS  PubMed  Google Scholar 

  • Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M (2012) microRNAs in cancer management. Lancet Oncol 13(6):e249–258

    CAS  PubMed  Google Scholar 

  • Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P (2012) Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 12(12):860–875

    CAS  PubMed  Google Scholar 

  • Lens SM, Voest EE, Medema RH (2010) Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 10(12):825–841

    CAS  PubMed  Google Scholar 

  • di Magliano MP, Logsdon CD (2013) Roles for KRAS in pancreatic tumor development and progression. Gastroenterology 144(6):1220–1229

    PubMed Central  CAS  PubMed  Google Scholar 

  • Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11(8):558–572

    CAS  PubMed  Google Scholar 

  • Ng JM, Curran T (2011) The Hedgehog‘s tale: developing strategies for targeting cancer. Nat Rev Cancer 11(7):493–501

    PubMed Central  CAS  PubMed  Google Scholar 

  • Palucka K, Banchereau J (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12(4):265–277

    PubMed Central  CAS  PubMed  Google Scholar 

  • Sansone P, Bromberg J (2012) Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 30(9):1005–1014

    PubMed Central  CAS  PubMed  Google Scholar 

  • Scott AM, Wolchok JD, Old LJ (2012) Antibody therapy of cancer. Nat Rev Cancer 12(4):278–287

    CAS  PubMed  Google Scholar 

  • Sun X, Han L, Seth P, Bian S, Li L, Csizmadia E, Junger WG, Schmelzle M, Usheva A, Tapper EB, Baffy G, Sukhatme VP, Wu Y, Robson SC (2013) Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice. Hepatology 57(1):205–216

    PubMed Central  CAS  PubMed  Google Scholar 

  • Thelen A, Scholz A, Benckert C, von Marschall Z, Schröder M, Wiedenmann B, Neuhaus P, Rosewicz S, Jonas S (2008) VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma. Int J Cancer 122(11):2471–2481

    CAS  PubMed  Google Scholar 

  • Trepel J, Mollapour M, Giaccone G, Neckers L (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10(8):537–549

    CAS  PubMed  Google Scholar 

  • Wade M, Li YC, Wahl GM (2013) MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 13(2):83–96

    PubMed Central  CAS  PubMed  Google Scholar 

  • Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537–549

    CAS  PubMed  Google Scholar 

  • Zitvogel L, Kepp O, Galluzzi L, Kroemer G (2012) Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 13(4):343–351

    CAS  PubMed  Google Scholar 

Literatur zu Abschnitt 28.2

  • Calle EE et al (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348:1625–1638

    PubMed  Google Scholar 

  • De Wijkerslooth TR et al (2012) Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 107:1570

    PubMed  Google Scholar 

  • Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoiable risks of cancer in the United States today. J Nath Cancer Inst 66:1191–1208

    CAS  Google Scholar 

  • Ewald N, Toepler M, Akinci A, Koer HU, Bretzel RG, Hardt PD (2005) Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review of current published data. Z Gastroenterol 43(12):1313–1317

    CAS  PubMed  Google Scholar 

  • Greenwald P, Weed DL (1995) Cancer prevention and control, cancer causes and control Harvard Report on Cancer Prevention. Causes of Human Cancer, Bd. 1. Marcel Dekker Inc, USA, S S55–S58

    Google Scholar 

  • Higginson J, Muir CS (1979) Environmental carcinogenesis: misconceptions and limitations to cancer control. J Natl Cancer Inst 63:1291–1298

    CAS  PubMed  Google Scholar 

  • - (2002) Weight control and physical activity Bd. 6. International Agency for Reseach on Cancer, Lyon, France

    Google Scholar 

  • Imperiale TF et al (2014) Multitargeted stool DNA testing for colorectal-cancer screening. N Engl J Med 370(14):1287–1297

    CAS  PubMed  Google Scholar 

  • Naumann M, Oromek GM, Hanisch E, Rösch W, Mössner J, Caspary W, Stein J (2005) Prospektive Evaluierung von Tumor M2-PK im Stuhl als neuen Screeningmarker für kolorektale Neoplasien – Ergebnisse einer multizentrischen prospektiven Studie. Z Gastroenterol (43):P507 doi:10.1055/s-2005-920298

    Google Scholar 

  • Schmiegel W et al (2008) S3-Leitlinie „Kolorektales Karzinom“. Z Gastroenterol (46):1–73

    Google Scholar 

  • Sharma P (2009) Barrett’s Esophagus. N Engl J Med 361:2548–2556

    CAS  PubMed  Google Scholar 

  • Strumberg D, Boeing H, Scheulen ME, Förster H, Seeber S (2004) Nutrition, lifestyle and risk of cancer: strategies for cancer prevention. Dtsch Med Wochenschr 129:1877–1882

    CAS  PubMed  Google Scholar 

  • WHO (2003) posting date. www.who.int/hpr/NPH/docs/who_fao_expert_report.pdf

    Google Scholar 

  • Wynder EL, Gori GB (1977) Contribution of the environment to cancer incidence: an epidemiologic exercise. J Natl Cancer Inst 58:825–832

    CAS  PubMed  Google Scholar 

Literatur zu Abschnitt 28.3

  • Aretz S (2010) Differentialdiagnostik und Früherkennung hereditärer gastrointestnaler Polyposis-Syndrome. Deutsches Ärzteblatt 107(10):163–173

    Google Scholar 

  • Aretz S (2014) Erbliche Tumorsyndrome. In: Moog U, Rieß O (Hrsg) Medizinische Genetik für die Praxis. Diagnostik, Beratung, Fallbeispiele. Thieme, Stuttgart, S 151–182

    Google Scholar 

  • Aretz S, Propping P, Noethen M (2006) Indikationen zur molekulargenetischen Diagnostik bei erblichen Krankheiten. Deutsches Ärzteblatt 103:A550–A558

    Google Scholar 

  • Bartsch DK, Gress TM, Langer P (2012) Familial pancreatic cancer – current knowledge. Nat Rev Gastroenterol Hepatol 9:445–453

    CAS  PubMed  Google Scholar 

  • Galiatsatos P, Foulkes WD (2006) Familial adenomatous polyposis. Am J Gastroenterol 101:385–398

    PubMed  Google Scholar 

  • Jass JR (2008) Colorectal polyposes: from phenotype to diagnosis. Pathol Res Pract 204:431–447

    PubMed  Google Scholar 

  • Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100(10):1043–1049 (Sep)

    CAS  PubMed  Google Scholar 

  • Lynch HAT et al (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76:1–18

    PubMed Central  CAS  PubMed  Google Scholar 

  • Oliveira C, Seruca R, Carneiro F (2009) Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 23:147–157

    CAS  PubMed  Google Scholar 

  • Rosty C, Parry S, Young JP (2011) Serrated polyposis: an enigmatic model of colorectal cancer predisposition. Patholog Res Int 157073 doi:10.4061/2011/157073

    Google Scholar 

  • Sampson JR, Jones N (2009) MUTYH-associated polyposis. Best Pract Res Clin Gastroenterol 23:209–218

    CAS  PubMed  Google Scholar 

  • Schulmann K, Pox C, Tannapfel A, Schmiegel W (2007) The patient with multiple intestinal polyps. Best Pract Res Clin Gastroenterol 21:409–426

    PubMed  Google Scholar 

  • Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP (2005) Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 124:380–391

    PubMed  Google Scholar 

  • Spier I, Holzapfel S, Steinke V, Aretz S (2013) Genetik gastrointestinaler Tumoren – Welche Folgen haben Keimbahnmutationen? Gastroenterologe 8:303–315

    Google Scholar 

  • Steinke V, Vogt S, Aretz S (2010) Klinik und Genetik des familiären Dickdarmkrebses. Medizinische Genetik 22:265–281

    Google Scholar 

  • Steinke V, Engel C, Büttner R, Schackert HK, Schmiegel WH, Propping P (2013) Hereditary nonpolyposis colorectal cancer (HNPCC)/Lynch syndrome. Dtsch Arztebl Int 110(3):32–38

    PubMed Central  PubMed  Google Scholar 

  • Zbuk KM, Eng C (2007) Hamartomatous polyposis syndromes. Nat Clin Pract Gastroenterol Hepatol 4:492–502

    CAS  PubMed  Google Scholar 

  • Zerres K (2003) Humangenetische Beratung. Deutsches Ärzteblatt 100:A2720–2727

    Google Scholar 

Literatur zu Abschnitt 28.4

  • Bundgaard-Nielsen M, Secher NH, Kehlet H (2009) ‚Liberal‘ vs. ‚restrictive‘ perioperative fluid therapy – a critical assessment of evidence. Acta Anaesthesiol Scand 53:1324–1328

    CAS  PubMed  Google Scholar 

  • García-Miguel FJ, Serrano-Aguilar PG, López-Bastida J (2003) Preoperative assessment. Lancet 362:1749–1757

    PubMed  Google Scholar 

  • Jambor C, Spannagl M, Zwissler B (2009) Perioperatives Management von Patienten mit Koronarstents bei nichtherzchirurgischen Eingriffen. Anästhesist 58:971–985

    CAS  Google Scholar 

  • Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, De Hert S, Fort I, Juanatey JR, Gorenek B, Heyndrckx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Luescher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Uva MS, Voudris V, Funck-Brentano C, Authors Task Force Members (2014) 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management oft he European Society of Anaesthesiology (ESA). Eur J Anaestesiol 31:517–573

    Google Scholar 

  • Lentschener C, Ozier Y (2002) Anesthesia for elective liver resection – some points should be revisited. Eur J Anaesthesiol 19:780–788

    CAS  PubMed  Google Scholar 

  • Mutlak H, Czerner S, Winter H, Zwissler B, Lackermeier P (2010) Präoperative Evaluierung und Risikoeinschätzung in der Thoraxchirurgie. Anästhesist 59:918–928

    CAS  Google Scholar 

  • Poldermans D, Bax JJ, Boersma E, deHert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Iung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OFM, Sicari R, van den Berghe G, Vermassen F (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 30:2769–2812

    PubMed  Google Scholar 

  • Priebe HJ (2011) Preoperative cardiac management of the patient for non-cardiac surgery: an individualized and evidence-based approach. Br J Anaesth 107:83–96

    PubMed  Google Scholar 

  • Smetana GW, Lawrence VA, Cornell JE, American College of Physicians (2006) Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 144:581–595

    PubMed  Google Scholar 

  • Smith I, Kranke P, Murat I, Smith A, O’Sullivan G, Soreide E, Spies C, in’t Vold B, European Society of Anaesthesiology (2011) Preoperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 28:556–569

    PubMed  Google Scholar 

  • Stuart PC (2006) The evidence base behind modern fasting guidelines. Best Pract Res Clin Anaesthesiol 20:457–469

    PubMed  Google Scholar 

  • Theilmeier C, Coldewey SM (2009) Perioperatives Risiko. In: Kochs E, Adams HA, Spiess C (Hrsg) Anästhesiologie, 2. Aufl. Thieme, Stuttgart, S 570–579

    Google Scholar 

  • Waurick K, Riess H, Van Aken H, Kessler P, Gogarten W, Volk T (2014) S-1-Leitlinie Rückenmarknahe Regionalanästhesien und Thrombembolieprophylaxe/antithrombotische Medikation. Anästh Intensivmed 55:464–492

    Google Scholar 

  • Weiß G, Jacob M (2008) Präoperative Nüchternheit. Anästhesist 57:857–872

    Google Scholar 

Literatur zu Abschnitt 28.5

  • Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, Samuel D, Bismuth H (2003) Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 238(4):508–518 (discussion 518–519)

    PubMed Central  PubMed  Google Scholar 

  • Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, Jaeck D, Saric J, Le Treut YP, Belghiti J, Mantion G, Mentha G, Association Française de Chirurgie (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244(4):524–535

    PubMed Central  PubMed  Google Scholar 

  • am Esch JS, Schmelzle M, Fürst G, Robson SC, Krieg A, Duhme C, Tustas RY, Alexander A, Klein HM, Topp SA, Bode JG, Häussinger D, Eisenberger CF, Knoefel WT (2012) Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study. Ann Surg 255(1):79–85

    Google Scholar 

  • Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A, Schirmacher P, Sempoux C, Thung SN, Torbenson M, Wee A, Yeh MM, Yeh SH, Le Bail B, Zucman-Rossi J, Bioulac-Sage P (2013) Focal nodular hyperplasia and hepatocellular adenoma around the world viewed through the scope of the immunopathological classification. Int J Hepatol 2013:268625

    PubMed Central  PubMed  Google Scholar 

  • Bickenbach KA, Denton B, Gonen M, Brennan MF, Coit DG, Strong VE (2013) Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol 20(3):780–787

    PubMed  Google Scholar 

  • van Bree SH, Vlug MS, Bemelman WA, Hollmann MW, Ubbink DT, Zwinderman AH, de Jonge WJ, Snoek SA, Bolhuis K, van der Zanden E, The FO, Bennink RJ, Boeckxstaens GE (2011) Faster recovery of gastrointestinal transit after laparoscopy and fast-track care in patients undergoing colonic surgery. Gastroenterology 141(3):872–880

    PubMed  Google Scholar 

  • Cucchetti A, Piscaglia F, Cescon M, Colecchia A, Ercolani G, Bolondi L, Pinna AD (2013) Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol 59(2):300–307

    PubMed  Google Scholar 

  • van Dam RM, Wong-Lun-Hing EM, van Breukelen GJ, Stoot JH, van der Vorst JR, Bemelmans MH, Damink OSW, Lassen K, Dejong CH, ORANGE II Study Group (2012) Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS® programme (ORANGE II-trial): study protocol for a randomised controlled trial. Trials 13:54 doi:10.1186/1745-6215-13-54

    PubMed Central  PubMed  Google Scholar 

  • Frutos MD, Abrisqueta J, Lujan J, Abellan I, Parrilla P (2013) Randomized prospective study to compare laparoscopic appendectomy versus umbilical single-incision appendectomy. Ann Surg 257(3):413–418

    PubMed  Google Scholar 

  • Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, Heath RM, Brown JM, UK MRC CLASICC Trial Group (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25(21):3061–3068

    PubMed  Google Scholar 

  • Marks JM, Phillips MS, Tacchino R, Roberts K, Onders R, DeNoto G, Gecelter G, Rubach E, Rivas H, Islam A, Soper N, Paraskeva P, Rosemurgy A, Ross S, Shah S (2013) Single-incision laparoscopic cholecystectomy is associated with improved cosmesis scoring at the cost of significantly higher hernia rates: 1-year results of a prospective randomized, multicenter, single-blinded trial of traditional multiport laparoscopic cholecystectomy vs single-incision laparoscopic cholecystectomy. J Am Coll Surg 216(6):1037–1047

    PubMed  Google Scholar 

  • Mullen JT, Moorman DW, Davenport DL (2009) The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 250(1):166–172

    PubMed  Google Scholar 

  • van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, Bonjer HJ, COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14(3):210–218. doi:10.1016/S1470-2045(13)70016-0

    PubMed  Google Scholar 

  • Quante M, Benckert C, Thelen A, Kaisers U, Jonas S (2011) Major abdominal surgery with continued dual antiplatelet therapy. Arch Surg 146(11):1334–1335 (author reply 1335–1336)

    PubMed  Google Scholar 

  • Quenet F, Goéré D, Mehta SS, Roca L, Dumont F, Hessissen M, Saint-Aubert B, Elias D (2011) Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg 254(2):294–301

    PubMed  Google Scholar 

  • Sahora K, Mino-Kenudson M, Brugge W, Thayer SP, Ferrone CR, Sahani D, Pitman MB, Warshaw AL, Lillemoe KD, Fernandez-Del Castillo CF (2013) Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg 258(3):466–475

    PubMed  Google Scholar 

  • Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH (2006) Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261–269

    CAS  PubMed  Google Scholar 

  • Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):405–414

    PubMed  Google Scholar 

  • Singer S, Szalai C, Briest S, Brown A, Dietz A, Einenkel J, Jonas S, Konnopka A, Papsdorf K, Langanke D, Löbner M, Schiefke F, Stolzenburg JU, Weimann A, Wirtz H, König HH, Riedel-Heller S (2013) Co-morbid mental health conditions in cancer patients at working age – prevalence, risk profiles, and care uptake. Psychooncology doi:10.1002/pon.3282

    Google Scholar 

  • Venkat R, Puhan MA, Schulick RD, Cameron JL, Eckhauser FE, Choti MA, Makary MA, Pawlik TM, Ahuja N, Edil BH, Wolfgang CL (2011) Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. Arch Surg 146(11):1277–1284

    PubMed  Google Scholar 

  • Zureikat AH, Moser AJ, Boone BA, Bartlett DL, Zenati M, Zeh HJ 3rd (2013) 250 robotic pancreatic resections: safety and feasibility. Ann Surg 258(4):554–562

    PubMed  Google Scholar 

Literatur zu Abschnitt 28.6

  • Bang YJ et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376(9742):687–697

    CAS  PubMed  Google Scholar 

  • Eisenhauer EA et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247

    CAS  PubMed  Google Scholar 

  • Goldman ID, Matherly LH (1985) The cellular pharmacology of methotrexate. Pharmacol Ther 25(1):77–102

    Google Scholar 

  • Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specifity. Nature 256(5517):495–497

    PubMed  Google Scholar 

  • Reilly JJ, Workman P (1993) Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerations. Cancer Chemother Pharmacol 32(6):411–418

    CAS  PubMed  Google Scholar 

  • Schmoll HJ, Höffken K, Possinger K (1999) Kompendium internistische Onkologie, 3. Aufl. Springer, Heidelberg, S 991–992

    Google Scholar 

  • Therasse P et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205–216

    CAS  PubMed  Google Scholar 

  • WHO (1976) Handbook for standardized cancer registries

    Google Scholar 

Literatur zu Abschnitt 28.7

  • Bosset JF, Roelofsen F, Morgan DA, Budach V, Coucke P, Jager JJ, Van der Steen-Banasik E, Trivière N, Stüben G, Puyraveau M, Mercier M (2003) Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Eur J Cancer 39:45–51

    CAS  PubMed  Google Scholar 

  • Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740

    CAS  PubMed  Google Scholar 

  • Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811–820

    PubMed Central  PubMed  Google Scholar 

Literatur zu Abschnitt 28.8

  • Colomer R et al (2007) N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97(5):823–831

    CAS  PubMed  Google Scholar 

  • Dennert G, Horneber M (2006) Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. Cochrane Database Syst Rev 3:CD005037

    PubMed  Google Scholar 

  • Dewey A et al (2007) Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev 1:CD004597

    PubMed  Google Scholar 

  • Ezzo JM et al (2006) Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev 2:CD002285

    PubMed  Google Scholar 

  • Horneber MA et al (2008) Mistletoe therapy in oncology. Cochrane Database Syst Rev 2:CD003297 doi:10.1002/14651858.CD003297.pub2

    PubMed  Google Scholar 

  • Kassab S et al (2009) Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev 2:CD004845 doi:10.1002/14651858.CD004845.pub2

    PubMed  Google Scholar 

Literatur zu Abschnitt 28.9

  • Feyer P, Ortner P (2009) Supportivtherapie in der Onkologie. Urban & Vogel, München

    Google Scholar 

  • Fornier M (2010) Denosumab: Second chapter in controlling bone metastases or a new book? J Clin Oncol 35:5127–5131

    Google Scholar 

  • Moehler M, Al-Batran SE, Andus T et al (2011) German S3-Guideline „Diagnosis and Treatment of Esophagogastric Cancer“. Z Gastroenterol 49:461–531

    CAS  PubMed  Google Scholar 

  • Multinational Association of Supportive Care in Cancer. MASCC Guidelines and Assessment Tools. Cliinical Practice Ressources. http://www.mascc.org/guidelines-and-tools

  • Nekolaichuk CL, Fainsinger RL, Lawlor PG (2005) A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton Classification System for Cancer Pain. Palliat Med 19:466–476

    PubMed  Google Scholar 

  • Ripamonti CI, Bandieri E, Roila F (2011) ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 22(Suppl 6):vi69–77

    PubMed  Google Scholar 

  • Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742

    CAS  PubMed  Google Scholar 

  • Weimann A, Braga M, Harsanyi L et al (2006) ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr 25:224–244

    CAS  PubMed  Google Scholar 

  • World Health Organization (2006) Cancer Pain Relief Bd. Volume 19, No. 1. WHO, Geneva

    Google Scholar 

Literatur zu Abschnitt 28.10

  • Delbrück H (2003) Krebsnachbetreuung. Springer, Heidelberg

    Google Scholar 

  • Delbrück H (2007) Rehabilitation and palliation of cancer patients. Springer, Heidelberg

    Google Scholar 

  • Lynch BM, Cerin E, Owen N, Hawkes AL, Aitken JF (2008) Prospective relationships of physical activity with quality of life among colorectal cancer survivors. J Clin Oncol 26(27):4480–4487

    PubMed  Google Scholar 

  • Pucciani F, Ringressi MN, Redditi S, Masi A, Giani I (2008) Rehabilitation of fecal incontinence after sphincter-saving surgery for rectal cancer: Encouraging Results. Dis Colon Rectum 51(10):1552–1558

    PubMed  Google Scholar 

Literatur zu Abschnitt 28.11

  • Bennett M, Cresswell H (2003) Factors influencing constipation in advanced cancer patients. Palliat Med 17(5):418–422

    PubMed  Google Scholar 

  • Davis MP, Walsh D (2002) Treatment of nausea and vomiting in advanced cancer. Support Care Cancer ####

    Google Scholar 

  • Klaschnik E (####) Palliativmedizin Praxis, Leitfaden für die palliativmedizinische Alltagsarbeit

    Google Scholar 

  • Ripamont C, Twycross R, Baines M et al (2001) Clinical-practice recommendations for the management of bowel obstruction with end-stage cancer. Support Care Cancer 9(4):223–233

    Google Scholar 

  • Schwarzer A, Nauck F, Klaschnik E (2005) Strong opiods and constipation. Schmerz 19(3):214–219

    CAS  PubMed  Google Scholar 

  • World Health Organisation (1980) Cancer pain relief. World Health Organization, Genf

    Google Scholar 

Literatur zu Abschnitt 28.12

  • Schumacher M, Schulgen G (2008) Methodik klinischer Studien: methodische Grundlagen der Planung, Durchführung und Auswertung, 3. Aufl. Springer, Berlin

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 310Klinik Nürnberg, Klinik für Hepato-Pankreato-Biliäre Chirurgie, Neumeyerstraße 48, 90411, Nürnberg, Deutschland

    Sven Jonas Prof. Dr. med.

  2. Institut für Humangenetik, Biomedizinisches Zentrum, Universitätsklinikum Bonn AöR, Sigmund-Freud-Straße 25, 53127, Bonn, Deutschland

    Stefan Aretz Prof. Dr. med.

  3. Abteilung Gesundheit und Pflege, Hochschule für Technik und Wirtschaft des Saarlandes, Goebenstraße 40, 66117, Saarbrücken, Deutschland

    Iris Burkholder Prof. Dr. rer. nat.

  4. Am Schafgarten 27, 67373, Dudenhofen, Deutschland

    Lutz Edler Dr. rer. nat.

  5. Strahlentherapie und Radiologische Onkologie, Marienhospital Düsseldorf, Rochusstraße 2, 40479, Düsseldorf, Deutschland

    Karl-Axel Hartmann Prof. Dr. med.

  6. Deutsche Krebsgesellschaft e. V., Kuno-Fischer-Straße 8, 14057, Berlin, Deutschland

    Jutta Hübner PD Dr. med.

  7. Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Leipzig, Liebigstraße 20, 04103, Leipzig, Deutschland

    Udo X. Kaisers Prof. Dr. med.

  8. Abteilung Gesundheit, Kreis Euskirchen, Jülicher Ring 32, 53879, Euskirchen, Deutschland

    Astrid Kaufmann Dr. med.

  9. Universitäres Krebszentrum Leipzig, Liebigstraße 20, 04103, Leipzig, Deutschland

    Florian Lordick Prof. Dr. med.

  10. Medizinische Klinik III, Hämatologie und Onkologie, Marienhospital Herne, Klinikum der Ruhr-Universität, Hölkeskampring 40, 44625, Herne, Deutschland

    Katharina Monz Dr. med.

  11. Klinik und Poliklinik für Anaesthesiologie und Intensivtherapie, Universitätsklinikum Leipzig, Liebigstraße 20, 04103, Leipzig, Deutschland

    Uta-Carolin Pietsch Dr. med.

  12. Klinik Bergisch Land, Im Saalscheid 5, 42369, Wuppertal-Ronsdorf, Deutschland

    Martin Raida Dr. med.

  13. Klinik für Allgemein-, Visceral- und Transplantationschirurgie, Campus Virchow-Klinikum Charité, Augustenburger Platz 1, 13353, Berlin, Deutschland

    Moritz Schmelzle PD Dr. med.

  14. Medizinische Klinik III, Hämatologie und Onkologie, Klinikum der Ruhr-Universität, Marienhospital Herne, Hölkeskampring 40, 44625, Herne, Deutschland

    Dirk Strumberg Prof. Dr. med.

  15. Medizinische Klinik, Florence-Nightingale-Krankenhaus, Kreuzbergstraße 79, 40489, Düsseldorf, Deutschland

    Andreas Winter Dr. med.

Authors
  1. Moritz Schmelzle PD Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sven Jonas Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dirk Strumberg Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Astrid Kaufmann Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefan Aretz Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Uta-Carolin Pietsch Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Udo X. Kaisers Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Katharina Monz Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Karl-Axel Hartmann Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jutta Hübner PD Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Florian Lordick Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Martin Raida Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Andreas Winter Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Iris Burkholder Prof. Dr. rer. nat.
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Lutz Edler Dr. rer. nat.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik, Florence-Nightingale-Krankenhaus, Düsseldorf, Germany

    J.F. Erckenbrecht

  2. Klinik für Hepato-Pankreato-Biliäre Chirurgie, 310Klinik Nürnberg, Nürnberg, Germany

    Sven Jonas

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schmelzle, M. et al. (2015). Grundlagen der gastrointestinalen Tumorerkrankungen. In: Erckenbrecht, J., Jonas, S. (eds) Viszeralmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-14301-4_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-14301-4_28

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-14300-7

  • Online ISBN: 978-3-642-14301-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation